SEC EDGAR filings, ownership reports, and insider transactions for Bellevue Global Life Science Investors LLC.
Recent SEC filings for Bellevue Global Life Science Investors LLC including 4, SCHEDULE 13G/A, SC 13G/A and more.
| Form type | Document | Filing | Description | Filing date | Reporting date | File number(s) |
|---|---|---|---|---|---|---|
| 4 | Open 4 document | View SEC filing for 4 | 19 Feb 2025 | 14 Feb 2025 | 001-41390 | |
| SCHEDULE 13G/A | Open SCHEDULE 13G/A document | View SEC filing for SCHEDULE 13G/A | 11 Feb 2025 | |||
| SC 13G/A | Open SC 13G/A document | View SEC filing for SC 13G/A | SC 13G/A | 14 Aug 2024 | ||
| SC 13G | Open SC 13G document | View SEC filing for SC 13G | SCHEDULE 13G | 08 Feb 2024 | ||
| 4 | Open 4 document | View SEC filing for 4 | 27 Mar 2023 | 23 Mar 2023 | 001-41390 | |
| 4 | Open 4 document | View SEC filing for 4 | 23 Feb 2023 | 21 Feb 2023 | 001-41390 | |
| 4 | Open 4 document | View SEC filing for 4 | FORM 4 SUBMISSION | 16 Feb 2023 | 14 Feb 2023 | 001-41390 |
| 3 | Open 3 document | View SEC filing for 3 | FORM 3 SUBMISSION | 09 Feb 2023 | 09 Feb 2023 | 001-41390 |
Bellevue Global Life Science Investors LLC files with the SEC under CIK 0001953768. This page aggregates EDGAR filings and related ownership activity.